Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CMPX Compass Therapeutics, Inc. Common Stock
$5.93 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CMPX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.0B
Enterprise value 803.8M
Trailing PE -16.388889153798
Forward PE -13.898693
PEG Ratio -13.898693
Enterprise to EBITDA -11.317
Enterprise to revenue 945.63056941176
Price to book MRQ 4.8389835
Price to sales TTM 1234.5722364706

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 850.0K
EBITDA -71024000
Diluted EPS TTM -0.45
Total Cash (MRQ) 219.9M
Current ratio (MRQ) 17.815
Operating Cash Flow (TTM) -45051000

CMPX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.